It has been proven that cells with high expression of IGFBP2 tend to aggregate in the vicinity of focal necrotic regions within gliomas, which indicates an important role in hypoxia-related pathways [26,27]. The gene discussed is IGFBP2; the disease is central nervous system cancer.